ESR2 and breast carcinoma: Western blot was first performed to examine PELP1, ERα, ERβ expression in MCF-7 (ERα, ERβ positive and PELP1 highly expressed) and MDA-MB-231 (ERα, ERβ negative and PELP1 highly expressed) breast carcinoma cells as control.